Discontinued — last reported Q2 '24

Business Segments · Business acquisitions

Sleep and Respiratory Care — Business acquisitions

Over 3 years (FY 2021 to FY 2024), Sleep and Respiratory Care — Business acquisitions shows an upward trend with a 151.0% CAGR.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ3 2018
Last reportedQ2 2024

How to read this metric

Higher values indicate aggressive inorganic growth strategies, while lower values suggest a focus on organic growth or capital preservation.

Detailed definition

Captures the total cash or consideration paid to acquire other companies or business units focused on sleep and respirat...

Peer comparison

Standard metric for growth-oriented healthcare firms; peers often disclose this in the cash flow statement under investing activities.

Metric ID: rmd_segment_sleep_and_respiratory_care_business_acquisitions

Historical Data

13 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24
Value$1.46M$9.74M$9.74M$9.74M$9.74M$19.28M$0.00$0.00$0.00$74.42M$3.30M$0.00$14.48M
QoQ Change+568.3%+0.0%+0.0%+0.0%+98.0%-100.0%-95.6%-100.0%
YoY Change+568.3%+98.0%-100.0%-100.0%-100.0%+286.0%
Range$0.00$74.42M
CAGR+115.0%
Avg YoY Growth+108.7%
Median YoY Growth-1.0%

Frequently Asked Questions

What is ResMed's sleep and respiratory care — business acquisitions?
ResMed (RMD) reported sleep and respiratory care — business acquisitions of $14.48M in Q2 2024.
What is the long-term trend for ResMed's sleep and respiratory care — business acquisitions?
Over 3 years (2021 to 2024), ResMed's sleep and respiratory care — business acquisitions has grown at a 151.0% compound annual growth rate (CAGR), from $5.83M to $92.19M.
What does sleep and respiratory care — business acquisitions mean?
The total investment cost for purchasing other businesses in the respiratory care space.